SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-074540
Filing Date
2019-12-20
Accepted
2019-12-19 20:34:46
Documents
8
Period of Report
2019-12-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1926605-1_8k.htm 8-K 28660
2 EXHIBIT 1.1 tm1926605d1_ex1-1.htm EX-1.1 253701
3 EXHIBIT 5.1 tm1926605d1_ex5-1.htm EX-5.1 8201
4 EXHIBIT 99.1 tm1926605d1_ex99-1.htm EX-99.1 10382
5 EXHIBIT 99.2 tm1926605d1_ex99-2.htm EX-99.2 11497
6 GRAPHIC tm1926605d1_ex5-1img001.jpg GRAPHIC 8741
7 GRAPHIC tm1926605d1_ex99-1img001.jpg GRAPHIC 7761
8 GRAPHIC tm1926605d1_ex99-2img001.jpg GRAPHIC 2914
  Complete submission text file 0001104659-19-074540.txt   340762
Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 191297492
SIC: 2834 Pharmaceutical Preparations